Tirzepatide is a dual incretin receptor agonist researched for its interaction with GLP-1 and GIP receptor signaling pathways.
Available in 10 mg, 15 mg, 30 mg, and 60 mg Lyophilized Vials
Research has shown tirzepatide may support cellular communication associated with metabolic regulation, glucose signaling, and energy balance. Studies focus on endocrine signaling pathways related to metabolic function and overall cellular homeostasis.
“A review from a customer who benefited from your product. Reviews can be a highly effective way of establishing credibility and increasing your company's reputation.”
Customer Name
“A review from a customer who benefited from your product. Reviews can be a highly effective way of establishing credibility and increasing your company's reputation.”
Customer Name
No products in the cart.